pharmaceutical kickback scheme

Johnson & Johnson $2.2 Billion Settlement (2013)

The Johnson & Johnson (J&J) $2.2 billion settlement in 2013 stands as another major milestone in healthcare fraud enforcement—particularly in curbing deceptive pharmaceutical marketing. The case centered on allegations that J&J and its subsidiaries promoted several prescription drugs, including Risperdal and Invega, for off-label uses not approved by the FDA. The company was also accused […]

Johnson & Johnson $2.2 Billion Settlement (2013) Read More »

Gavel, stethoscope, and medicine tablets — illustrating the intersection of healthcare and medical malpractice law.

Pfizer $2.3 Billion Settlement (2009)

The Pfizer $2.3 billion settlement in 2009 was a watershed moment in healthcare fraud enforcement. Not only was it the largest healthcare fraud settlement in U.S. history at the time, but it also showcased the power of whistleblowers in holding the world’s biggest pharmaceutical companies accountable. The case revolved around allegations of Pfizer illegally promoting

Pfizer $2.3 Billion Settlement (2009) Read More »